Li Long
Corporate Officer/Principal at KEZAR LIFE SCIENCES, INC.
Profile
Li Long is currently working as Vice President-Immunology Clinical Development at Kezar Life Sciences, Inc. Prior to this, Dr. Long worked as Senior Director-Clinical Development at Principia Biopharma, Inc. Dr. Long holds a doctorate degree from McGill University.
Li Long active positions
Companies | Position | Start |
---|---|---|
KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | - |
Former positions of Li Long
Companies | Position | End |
---|---|---|
PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | - |
Training of Li Long
McGill University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KEZAR LIFE SCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Li Long